Kenía - enska - Pharmacy and Poisons Board

medisel kenya limited p.o box 540-01000 thika - griseofulvin bp - film-coated tablet - griseofulvin bp 250 mg - antifungals for systemic use

Kenía - enska - Pharmacy and Poisons Board

galaxy pharmaceutical ltd p.o. box 39107-00623, nairobi - griseofulvin bp - tablet - 250 mg per tablet - antibiotics antifungals for topical use

Bandaríkin - enska - NLM (National Library of Medicine)

rebel distributors corp - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin 125 mg in 5 ml - major indications for griseofulvin oral suspension are: griseofulvin inhibits the growth of those genera of fungi that commonly cause ringworm infections of the hair, skin, and nails, such as: note: prior to therapy, the type of fungi responsible for the infection should be identified. the use of the drug is not justified in minor or trivial infections which will respond to topical antifungal agents alone. it is not effective in: this drug is contraindicated in patients with porphyria, hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin. two cases of conjoined twins have been reported in patients taking griseofulvin during the first trimester of pregnancy. griseofulvin should not be prescribed to pregnant patients.

Bandaríkin - enska - NLM (National Library of Medicine)

pedinol pharmacal, inc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin 250 mg - gris-peg (griseofulvin ultramicrosize) is indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: trichophyton rubrum , trichophyton tonsurans, trichophyton mentagrophytes, trichophyton interdigitalis,trichophyton verrucosum, trichophyton megnini, trichophyton gallinae, trichophyton crateriform, trichophyton sulphureum, trichophyton schoenleini, microsporum audouini, microsporum canis, microsporum gypseum and epidermophyton floccosum. note: prior to therapy, the type of fungi responsible for the infection should be identified. the use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. griseofulvin is not effective in the following: bacterial inf

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca - griseofulvin - tablet - 125 mg

Sádi-Arabía - enska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca - griseofulvin - tablet - 500 mg

Bandaríkin - enska - NLM (National Library of Medicine)

corepharma, llc - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin 125 mg - ultramicrosize griseofulvin tablets, usp are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete's foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber's itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: trichophyton rubrum, trichophyton tonsurans, trichophyton mentagrophytes, trichophyton interdigitalis, trichophyton verrucosum, trichophyton megnini, trichophyton gallinae, trichophyton crateriform, trichophyton sulphureum, trichophyton schoenleini, microsporum audouini, microsporum canis, microsporum gypseum and epidermophyton floccosum. note: prior to therapy, the type of fungi responsible for the infection should be identified. the use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. griseofulvin is not effective in the following: bacterial in

Bangladess - enska - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - griseofulvin - tablet - 500 mg

Singapúr - enska - HSA (Health Sciences Authority)

goldplus universal pte ltd - griseofulvin - tablet, film coated - 500.00 mg - griseofulvin 500.00 mg

Bandaríkin - enska - NLM (National Library of Medicine)

sigmapharm laboratories, llc - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - griseofulvin is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy, hair and nails, namely: tinea corporis tinea pedis tinea cruris tinea barbae tinea capitis tinea unguium when caused by one or more of the following species of fungi: epidermophyton floccosum microsporum audouinii microsporum canis microsporum gypseum trichophyton crateriform trichophyton gallinae trichophyton interdigitalis trichophyton megnini trichophyton mentagrophytes trichophyton rubrum trichophyton schoenleini trichophyton sulphureum trichophyton tonsurans trichophyton verrucosum note: prior to therapy, a dermatophyte should be identified as responsible for the infection. prior to initiating treatment, appropriate specimens for laboratory testing (koh preparation, fungal culture, or nail biopsy) should be obtained to confirm the diagnosis. griseofulvin is not effective in the following: bacterial infections candidiasis (moniliasis) histoplasmosis actinomycosis spo